Panic disorder, interstitial cystitis, and mast cells.

T. Theoharides
DOI: https://doi.org/10.1097/01.JCP.0000132451.50725.EE
2004-08-01
Journal of Clinical Psychopharmacology
Abstract:Panic disorder (PD) is a psychiatric condition characterized by neuropsychologic symptoms including recurrent episodes of sudden unpredictable apprehension and associated autonomic manifestations involving cardiorespiratory systems, neurologic, gastrointestinal, and cognitive symptoms. It is associated with high levels of stress. Genetic evidence has mapped a PD syndrome to chromosome 13q in 60 multiplex families with PD and bladder problems suggestive of interstitial cystitis (IC); other evidence from genetic linkage studies associated PD with a polymorphism in the adenosine 2A receptor. Families with PD also had a higher incidence of migraines, which are also prevalent in IC patients. The genetic linkage studies focused on families with PD and did not have definitive diagnosis of IC. A recent paper published in the Archives of General Psychiatry reported findings from a collaboration between psychiatry and urology. The study began with patients with well-characterized IC and found increased rates of PD in the IC patients and their first degree relatives. IC is a disorder of the urinary bladder characterized by urgency, frequency, nocturia, and chronic pelvic pain. IC patients can be broadly grouped in those with bladder inflammation (some of whom may also have Hunner ulcers) on biopsy, presenting with more pronounced symptoms and those with minimal or no inflammation. The only pathologic finding that was correlated to IC symptoms was an increased number of mast cells that have been repeatedly documented and shown to be activated in the bladder of IC patients. A number of other conditions occur with higher frequency in IC patients and include allergies, irritable bowel syndrome, fibromyalgia and migraines. The publication by Weissman et al is the first report linking IC genetically to PD, let alone to any other disorder; this paper discussed the possibility that mast cells may serve as a link between the two disorders. This is an exciting development since we had proposed that IC is a neuroimmunoendocrine syndrome and that stress-related molecules may be involved. Stress has been shown to stimulate mast cells, as well as worsen the symptoms of IC. Moreover, acute stress was shown to activate bladder mast cells and lead to sterile bladder inflammation. Neurotransmitters and neuropeptides secreted under stress could then further activate mast cells; in fact, adenosine has been shown to activate mast cells. One of the molecules released from mast cells is serotonin that has been implicated in the pathophysiology of panic disorders. It is, therefore, of interest that drugs used for the treatment of PD, benzodiazepines, and tricyclic antidepressants can inhibit mast cells. In fact, mast cells have been proposed as an immune gate to the brain, as well as a sensor of Guest Editorial
What problem does this paper attempt to address?